Perflenapent/Perflisopent
全氟戊烷/全氟异戊烷
Report date: 2022/03/04 16:16:40
Base Information
Drug NamePerflenapent/Perflisopent
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Perflenapent
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSonus Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSonus Pharmaceuticals Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A